Detalhe da pesquisa
1.
Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
Histopathology;
84(3): 451-462, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37988282
2.
The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 study.
Gynecol Oncol;
186: 17-25, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38554625
3.
PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Potential Immunotherapeutic Target and Possible Diagnostic Pitfall.
Int J Gynecol Pathol;
42(1): 35-42, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35512215
4.
Incidence of catastrophic health spending in Indonesia: insights from a Household Panel Study 2018-2019.
Int J Equity Health;
22(1): 185, 2023 09 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37674199
5.
Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologists.
Mod Pathol;
35(2): 142-151, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34493822
6.
The Immune Checkpoint Inhibitor LAG-3 and Its Ligand GAL-3 in Vulvar Squamous Neoplasia.
Int J Gynecol Pathol;
41(2): 113-121, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33782343
7.
MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status.
Int J Gynecol Pathol;
41(1): 1-11, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33577226
8.
Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Int J Gynecol Pathol;
41(Suppl 1): S64-S89, 2022 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36305535
9.
Using measures of quality of care to assess equity in health care funding for primary care: analysis of Indonesian household data.
BMC Health Serv Res;
22(1): 1349, 2022 Nov 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36376946
10.
MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition.
Mod Pathol;
34(3): 627-636, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33011747
11.
PD-L1 and Mismatch Repair Status in Uterine Carcinosarcomas.
Int J Gynecol Pathol;
40(6): 563-574, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33323859
12.
Synthesis of diagnostic quality cancer pathology images by generative adversarial networks.
J Pathol;
252(2): 178-188, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32686118
13.
Effects on Smoking Behavior of Switching Menthol Smokers to Non-menthol Cigarettes.
Nicotine Tob Res;
23(11): 1921-1927, 2021 10 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33983396
14.
Effects on time to lapse of switching menthol smokers to non-menthol cigarettes prior to a cessation attempt: a pilot study.
Tob Control;
30(5): 574-577, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32719011
15.
Putative precancerous lesions of vulvar squamous cell carcinoma.
Semin Diagn Pathol;
38(1): 27-36, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32948383
16.
Supporting student nurses to develop healthy conversation skills.
Br J Community Nurs;
26(11): 554-559, 2021 Nov 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34731034
17.
Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia.
Mod Pathol;
33(6): 1182-1192, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32139873
18.
LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for Immunotherapy.
Int J Gynecol Pathol;
39(3): 203-212, 2020 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32267656
19.
Expression of the Immune Checkpoints LAG-3 and PD-L1 in High-grade Serous Ovarian Carcinoma: Relationship to Tumor-associated Lymphocytes and Germline BRCA Status.
Int J Gynecol Pathol;
39(6): 558-566, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31851060
20.
ß-catenin and PD-L1 expression in mismatch repair deficient endometrial carcinomas.
Int J Gynecol Cancer;
30(7): 993-999, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32376735